Billionaire Profile

Global Rank

#3009

Image: Unsplash Contributor | Unsplash License | via Unsplash

Xie Juhua & family

CEO, Pharmaceuticals

CHINA

Real-Time Net Worth

$1.114B

Estimated based on Pharmaceuticals stock value as of March 6, 2026

+3.42% (24h)

Age

Source

Pharmaceuticals

Industry

Healthcare

Citizenship

CHINA

Biography

Xie Juhua, a prominent figure in China's pharmaceutical industry, is the director and largest individual shareholder of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd. With a career spanning the pharmaceutical sector, Xie has built a significant net worth of $4.2 billion through strategic investments and leadership. His contributions have been instrumental in the development of cardiovascular and anti-tumor drugs, showcasing his impact on healthcare. Xie's career exemplifies entrepreneurial success and the ability to create substantial wealth within the healthcare industry.

Fact Checked

Verified by Editorial Team

Live Data

Updated 3/6/2026

Wealth Over Time

Portfolio Holdings

Nanjing King-Friend Biochemical Pharmaceutical Co Ltd

Information not available

Information not available employees

In-Depth Profile

Early Life

Information regarding Xie Juhua's early life and education is not readily available in the search results. Further research would be needed to gather this information.

Rise to Success

Xie Juhua's rise to success is primarily attributed to her pivotal role as a director and the largest individual shareholder in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd. The company's main products include cardiovascular and anti-tumor drugs. Xie's strategic investments and leadership within Kingfriend have been key drivers of her wealth accumulation. Her son, Tang Yongqun, currently chairs Kingfriend, indicating a continued family involvement in the business.

Key Business Strategies

The key business strategy has been focusing on pharmaceutical development, especially in the cardiovascular and anti-tumor drug markets. Xie Juhua's shareholding in Kingfriend, with over 439 million shares as of July 2022, demonstrates her commitment to the company's growth.

Philanthropy

There is no detailed information about Xie Juhua's philanthropic activities found in the provided search results. Further research is needed to identify specific initiatives and contributions.

Career Milestones

Information not available

Director

Serves as a director for Nanjing King-Friend Biochemical Pharmaceutical Co Ltd.

Philanthropy & Social Impact

Information not available

Undisclosed

Information not available

Business Philosophy & Leadership

Notable Quotes

"Information not available"

Leadership Principles

Information not available

Controversies & Challenges

Information not available

Compare Xie Juhua & family

Net Worth Face-off

Xie Juhua & family vs Elon Musk

Compare Wealth →

Net Worth Face-off

Xie Juhua & family vs Jeff Bezos

Compare Wealth →

Net Worth Face-off

Xie Juhua & family vs Mark Zuckerberg

Compare Wealth →